Get started
Author

Olusola Joseph Olarewaju

Observed names: Joseph Olusola Olarewaju, Olarewaju , O. J., Olarewaju Olusola Joseph, Olusola J. Olarewaju, Olusola JOSEPH Olarewaju, Olusola Olarewaju
ORCID: 0000-0003-0563-6932
Observed ORCID: 0000-0003-0563-6932
OpenAlex ID: A5036050875
CYP2B6*6 Genotype Specific Differences in Artemether‐Lumefantrine Disposition in Healthy Volunteers
2019 · Sa'ad T. Abdullahi, Julius O. Soyinka, et al. · The Journal of Clinical Pharmacology · 9
PDF
Allele and Genotype Frequencies of Cytochrome P450 2B6 516G>T Single Nucleotide Polymorphism in HIV-Negative and HIV-Infected Adult Nigerian Populations
2016 · Abdullahi Sa'ad Toyin, Soyinka Julius Olugbenga, et al. · American Journal of Therapeutics · 8
Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by CYP2B6 c.516G>T Genotypes
2019 · Sa’ad T. Abdullahi, Julius O. Soyinka, et al. · Antimicrobial Agents and Chemotherapy · 5
Pharmacogenetics of artemether‐lumefantrine influence on nevirapine disposition: Clinically significant drug–drug interaction?
2018 · Sa'ad T. Abdullahi, Adeniyi Olagunju, et al. · British Journal of Clinical Pharmacology · 5
CYP2D6 Pharmacogenetics in Nigerian Sickle Cell Disease: Phase 1 of Implementing Pharmacogenomics Testing for Effective Care and Treatment in Africa (iPROTECTA) program
2025 · Babatunde Adeagbo, Olusola Olarewaju, et al. · Gates Open Research · 3
PDF
Complete androgen insensitivity syndrome with Sertoli cell tumour in a 27-year-old married woman: a case report
2023 · Mumini Wemimo Rasheed, Najeem Adedamola Idowu, et al. · African Journal of Urology · 3
PDF
Pro-Inflammatory Cytokines in Patients With Chronic Phase-Chronic Myeloid Leukaemia Treated With Imatinib: Any Role in the Monitoring of Treatment Response?
2025 · Kehinde A. Taiwo, Ibrahim O. Ahmed, et al. · Biomarker Insights · 2
Head and Neck Lymphoma: Clinico-demographic Profile and Pattern of Presentations in a South Western Nigeria Tertiary Institution
2024 · Adewale Adejobi, Oluwatobi Ojediran, et al. · Nigerian Dental Journal · 1
PDF
Real-world experience with second and third generation tyrosine kinase inhibitors in imatinib-resistant Nigerian patients with BCR::ABL1 positive chronic myeloid leukaemia.
2026 · Ibrahim Oluwaseun Ahmed, Temilola Owojuyigbe, et al. · Journal of Clinical Oncology
Imatinib-related toxicity profile in patients with gastrointestinal stromal tumors seen over a twenty-year period in Ile-Ife, Nigeria.
2026 · Oludolapo Abidemi Omoyiola, Ramoni Ayodele Bolarinwa, et al. · Journal of Clinical Oncology
Association between serum vitamins and COVID-19 infection: a cross-sectional study of healthcare workers in a Nigerian tertiary hospital
2026 · Tajudin Adesegun Adetunji, Olusola Akanni Jeje, et al. · BMC Infectious Diseases
Association of Markers of Haemolysis and Endothelial Dysfunction with Disease Severity and ABO Phenotype in Individuals with Sickle Cell Anaemia in South-West of Nigeria
2026 · Mfonobong George Bassey, Ogbenna Abiola Ann, et al.
Prognostic biomarkers for colorectal cancer in a Nigerian population.
2025 · Oludolapo Abidemi Omoyiola, Olusegun Isaac Alatise, et al. · Journal of Clinical Oncology
PDF
Trough plasma nevirapine levels, immunologic and virologic responses in composite CYP2B6*6/*18 HIV‐infected adult Nigerian patients
2022 · Sa'ad T. Abdullahi, Julius O. Soyinka, et al. · Basic & Clinical Pharmacology & Toxicology
Effect Of Covid-19 Pandemic On Access To Tyrosine Kinase Inhibitors In Nigeria
2021 · Olarewaju , O. J., Bolarinwa , R. A. A., et al. · Nigerian Journal of Haematology
PDF
Challenges of Management: Necrotizing Fasciitis Complicating Acute Lymphoblastic Leukaemia in a Resource Limited Setting
2017 · Olarewaju , O. J., Akinola , N. O., et al. · Nigerian Journal of Haematology
PDF
Works count: 16
Citation count: 36
H-index: 4
I10-index:
Year
Topic
Type